Insider Trading & Ownership - Fairmount Funds Management LLC

Real time insider trading transaction history:

  • Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
  • Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period
Insider Trading Transactions for Fairmount Funds Management LLC
Common stock purchase or sale:
Transaction
Date
Reported
DateTime
CompanySymbolInsider
Relationship
Shares
Traded
Average
Price
Total
Amount
Shares
Owned
Filing
2024-01-22
Purchase
2024-01-24
6:44 pm
Viridian Therapeutics Inc.VRDNFairmount Funds Management LLC
Fairmount Healthcare Fund GP LLC
Fairmount Healthcare Fund II GP LLC
Fairmount Healthcare Fund L.P.
Fairmount Healthcare Fund II L.P.
See Remarks
10% Owner
476,190$21$9,999,9901,845,813
(Indirect)
View
2023-09-29
Purchase
2023-10-03
4:00 pm
Dianthus Therapeutics Inc.DNTHFairmount Funds Management LLC
Kiselak Tomas
Harwin Peter Evan
Director
10% Owner
24,670$13.63$336,2521,928,503
(Indirect)
View
2023-09-26
Purchase
2023-09-28
5:09 pm
Dianthus Therapeutics Inc.DNTHFairmount Funds Management LLC
Kiselak Tomas
Harwin Peter Evan
Director
10% Owner
30,000$13.15$394,5001,903,833
(Indirect)
View
2023-09-19
Purchase
2023-09-21
4:23 pm
Dianthus Therapeutics Inc.DNTHFairmount Funds Management LLC
Kiselak Tomas
Harwin Peter Evan
Director
10% Owner
30,000$13.2$396,0001,873,833
(Indirect)
View
2023-09-12
Purchase
2023-09-13
9:17 pm
Dianthus Therapeutics Inc.DNTHFairmount Funds Management LLC
Kiselak Tomas
Harwin Peter Evan
Director
10% Owner
24,254$11.2$271,6801,850,333
(Indirect)
View
2023-07-13
Purchase
2023-07-17
8:00 pm
Apogee Therapeutics Inc.APGEFairmount Funds Management LLC
Fairmount Healthcare Fund L.P.
Fairmount Healthcare Fund II L.P.
Fairmount Healthcare Co-Invest II L.P.
Kiselak Tomas
Harwin Peter Evan
Director
2,941,176$17$49,999,992988,045
(Indirect
Direct)
View
2023-06-09
Purchase
2023-06-13
4:07 pm
Cogent Biosciences Inc.COGTFairmount Funds Management LLC
See Remarks
10% Owner
800,000$12$9,600,0003,626,389
(Indirect)
View
2022-08-17
Purchase
2022-08-19
4:32 pm
Viridian Therapeutics Inc.VRDNFairmount Funds Management LLC
Fairmount Healthcare Fund GP LLC
Fairmount Healthcare Fund II GP LLC
Fairmount Healthcare Fund L.P.
Fairmount Healthcare Fund II L.P.
See Remarks
10% Owner
425,531$23.5$9,999,9791,369,623
(Indirect)
View
2022-06-16
Purchase
2022-06-21
10:02 am
Cogent Biosciences Inc.COGTFairmount Funds Management LLC
See Remarks
10% Owner
1,200,000$8.25$9,900,0002,826,389
(Indirect)
View
2021-09-21
Purchase
2021-09-23
09:30 am
Viridian Therapeutics Inc.VRDNFairmount Funds Management LLC
Fairmount Healthcare Fund GP LLC
Fairmount Healthcare Fund II GP LLC
Fairmount Healthcare Fund L.P.
Fairmount Healthcare Fund II L.P.
Director
10% Owner
909,000$11$9,999,0001,077,283
(Indirect)
View

Stock options: Exercise, Award, Grant, Conversion
Transaction
Date
Reported
DateTime
Exercisable
Expiration
CompanySymnbolInsider
Relationship
Shares
Traded
Conversion
Price
Shares
Owned
Filing
2024-03-28
Other
2024-04-01
6:32 pm
N/A
N/A
Viridian Therapeutics Inc.VRDNFairmount Funds Management LLC
Fairmount Healthcare Fund GP LLC
Fairmount Healthcare Fund II GP LLC
Fairmount Healthcare Fund L.P.
Fairmount Healthcare Fund II L.P.
Director
10% Owner
49,857$01,990,722
(Indirect)
View
2024-04-01
Other
2024-04-01
6:21 pm
N/A
N/A
Dianthus Therapeutics Inc.DNTHFairmount Funds Management LLC
Kiselak Tomas
Director
58,857$02,880,551
(Indirect)
View
2024-03-28
Other
2024-04-01
6:19 pm
N/A
N/A
Cogent Biosciences Inc.COGTFairmount Funds Management LLC
Director
310,679$05,366,757
(Indirect)
View
2024-03-28
Other
2024-04-01
5:44 pm
N/A
N/A
Apogee Therapeutics Inc.APGEFairmount Funds Management LLC
Fairmount Healthcare Fund L.P.
Fairmount Healthcare Fund II L.P.
Kiselak Tomas
Harwin Peter Evan
Director
498,765$09,006,126
(Indirect)
View
2024-02-16
Option Award
2024-02-16
6:43 pm
N/A
N/A
Cogent Biosciences Inc.COGTFairmount Funds Management LLC
10% Owner
1,166,666$7.54,727,141
(Indirect)
View
2024-02-16
Option Award
2024-02-16
6:43 pm
N/A
N/A
Cogent Biosciences Inc.COGTFairmount Funds Management LLC
10% Owner
1,500$75004,727,141
(Indirect)
View
2024-01-29
Other
2024-01-31
4:31 pm
N/A
N/A
Apogee Therapeutics Inc.APGEFairmount Funds Management LLC
Fairmount Healthcare Fund L.P.
Fairmount Healthcare Fund II L.P.
Fairmount Healthcare Co-Invest II L.P.
Kiselak Tomas
Harwin Peter Evan
Director
943,695$01,046,027
(Indirect)
View
2024-01-22
Option Award
2024-01-24
7:02 pm
N/A
N/A
Dianthus Therapeutics Inc.DNTHFairmount Funds Management LLC
Kiselak Tomas
Harwin Peter Evan
Director
10% Owner
832,333$123,595,170
(Indirect)
View
2024-01-22
Option Award
2024-01-24
7:02 pm
N/A
N/A
Dianthus Therapeutics Inc.DNTHFairmount Funds Management LLC
Kiselak Tomas
Harwin Peter Evan
Director
10% Owner
834,334$123,595,170
(Indirect)
View
2023-12-29
Other
2023-12-29
5:00 pm
N/A
N/A
Spyre Therapeutics Inc.SYREFairmount Funds Management LLC
Fairmount Healthcare Fund L.P.
Fairmount Healthcare Fund II L.P.
Fairmount Healthcare Co-Invest L.P.
Kiselak Tomas
Harwin Peter Evan
Director
10% Owner
3,841,518$05,485,719
(Indirect)
View
2023-12-07
Option Award
2023-12-11
5:41 pm
N/A
N/A
Spyre Therapeutics Inc.SYREFairmount Funds Management LLC
Fairmount Healthcare Fund L.P.
Fairmount Healthcare Fund II L.P.
Fairmount Healthcare Co-Invest L.P.
Kiselak Tomas
Harwin Peter Evan
Director
10% Owner
16,667$60016,667
(Indirect)
View
2023-11-24
Conversion
2023-11-28
4:05 pm
N/A
N/A
Spyre Therapeutics Inc.AGLEFairmount Funds Management LLC
Fairmount Healthcare Fund L.P.
Fairmount Healthcare Fund II L.P.
Fairmount Healthcare Co-Invest L.P.
Kiselak Tomas
Harwin Peter Evan
Director
10% Owner
3,521,367$04,250,938
(Indirect)
View
2023-10-30
Option Award
2023-11-01
9:05 pm
N/A
N/A
Viridian Therapeutics Inc.VRDNFairmount Funds Management LLC
Fairmount Healthcare Fund GP LLC
Fairmount Healthcare Fund II GP LLC
Fairmount Healthcare Fund L.P.
Fairmount Healthcare Fund II L.P.
See Remarks
10% Owner
48,463$825.3748,463
(Indirect)
View
2023-09-11
Option Award
2023-09-13
9:17 pm
N/A
2033-09-10
Dianthus Therapeutics Inc.DNTHFairmount Funds Management LLC
Kiselak Tomas
Harwin Peter Evan
Director
10% Owner
6,500$01,850,333
(Indirect)
View

Ownership
2023-09-13
8:55 pm
N/A
N/A
Dianthus Therapeutics Inc.DNTHFairmount Funds Management LLC
Kiselak Tomas
Harwin Peter Evan
Director
10% Owner
0$01,819,579
(Indirect)
View
2023-07-13
Option Award
2023-07-17
8:00 pm
N/A
2033-07-13
Apogee Therapeutics Inc.APGEFairmount Funds Management LLC
Fairmount Healthcare Fund L.P.
Fairmount Healthcare Fund II L.P.
Fairmount Healthcare Co-Invest II L.P.
Kiselak Tomas
Harwin Peter Evan
Director
95,516$0988,045
(Direct)
View

Ownership
2023-07-13
6:39 pm
N/A
N/A
Apogee Therapeutics Inc.APGEFairmount Funds Management LLC
Fairmount Healthcare Fund L.P.
Fairmount Healthcare Fund II L.P.
Director
0$06,743,321
(Indirect)
View

Ownership
2023-06-30
5:32 pm
N/A
N/A
Aeglea BioTherapeutics Inc.AGLEFairmount Funds Management LLC
Fairmount Healthcare Fund L.P.
Fairmount Healthcare Fund II L.P.
Fairmount Healthcare Co-Invest L.P.
Kiselak Tomas
Harwin Peter Evan
Director
10% Owner
0$0536,284,540
(Indirect)
View

Ownership
2020-10-30
11:43 am
N/A
N/A
MIRAGEN THERAPEUTICS INC.MGENFairmount Funds Management LLC
Fairmount Healthcare Fund GP LLC
Fairmount Healthcare Fund II GP LLC
Fairmount Healthcare Fund L.P.
Fairmount Healthcare Fund II L.P.
See Remarks
0$0131,717,393
(Indirect)
View
2020-10-27
Other
2020-10-29
11:30 am
N/A
N/A
MIRAGEN THERAPEUTICS INC.MGENFairmount Funds Management LLC
Fairmount Healthcare Fund GP LLC
Fairmount Healthcare Fund II GP LLC
Fairmount Healthcare Fund L.P.
Fairmount Healthcare Fund II L.P.
See Remarks
625,247$01,063,749
(Indirect)
View
2020-07-06
Other
2020-07-08
7:29 pm
N/A
N/A
Unum Therapeutics Inc.UMRXFairmount Funds Management LLC
10% Owner
6,280,590$011,369,087
(Indirect)
View